Delivery Order SPE2DB22D2006-SPE2DB25FW3LL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,313.06 to AmerisourceBergen Drug Corp for AZSTARYS 26.1 mg-5.2 mg capsules (100-count supply). This firm fixed price, non-set-aside delivery order was awarded on June 30, 2025, with an ultimate completion date of July 1, 2025. The contract represents a standard pharmaceutical procurement under the Defense Logistics Agency's medical supply operations, with performance taking place at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,370.10 firm fixed price delivery order for Azstarys 39.2 mg-7.8 mg capsules (100-count) on August 7, 2025, with completion scheduled for August 8, 2025. This non-set-aside contract represents a single delivery under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,856.69 to AmerisourceBergen Drug Corp for AZSTARYS CAPS 39.2MG/7.8MG on August 20, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,719.10 to AmerisourceBergen Drug Corp for AZSTARYS 26.1 mg-5.2 mg capsules (100-count package) on March 5, 2025. This competitive award, which carries an ultimate completion date of March 6, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,782.29 to AmerisourceBergen Drug Corp for AZSTARYS 39.2 mg-7.8 mg capsules (100-count) on August 19, 2025, with completion scheduled for August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,921.48 to AmerisourceBergen Drug Corp for 100 capsules of AZSTARYS 26.1 mg-5.2 mg, a prescription medication. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 9, 2025. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,668.99 on August 18, 2025, for the supply of Azstarys 52.3 mg-10.4 mg capsules (100-count unit). This firm fixed-price contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 19, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, reflecting the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,034.80 by the Defense Logistics Agency (DLA) on September 9, 2025, with completion expected by September 10, 2025. The contract, issued under a firm fixed-price arrangement with no set-aside designation, calls for the delivery of Azstarys 39.2 mg-7.8 mg capsules (100-count units), a prescription medication used to treat...
- This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This delivery order, valued at $1,436.84, awards AmerisourceBergen Drug Corp a competitively awarded, firm fixed-price contract for the supply of Azstarys 39.2 mg-7.8 mg capsules (100-count units) effective through September 16, 2025. The award was made by the Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical procurement to support military and veteran healthcare systems. The contract carries no set-aside designation, indicating open competition among eligible...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3LLDelivery Order
The Defense Logistics Agency awarded a $5,531.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azstarys 26.1 mg–5.2 mg capsules (100 count). This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents a component of AmerisourceBergen's substantial role in the Defense Logistics Agency's pharmaceutical supply chain, which also encompasses support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/14/25 |